Minovia Therapeutics
Mitochondrial Augmentation Cell-therapy Platform
StartupMinovia Therapeutics is a -based startup in the Health Tech & Life Sciences sector, established in 2011. Mitochondrial Augmentation Cell-therapy Platform. The company has raised a total of $28.35M across 5 funding rounds, currently at the Public stage. Minovia Therapeutics was founded by Natalie Yivgi-Ohana. Key investors include 4T Ventures, eit health, The Yozma Group. The company has 11-50 employees. Core technologies: Biologicals, Cells.
With $28.35M in total funding, Minovia Therapeutics is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePublic
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQ
- Last Round$350K
- 4T Ventures
- eit health
- The Yozma GroupLead
Natalie Yivgi-OhanaCEO & Co-founder
11 articles covered by sources including www.globenewswire.com,
www.israel21c.org,
www.businesswire.com,
www.fiercebiotech.com,
bostonrealestatetimes.com.
What does Minovia Therapeutics do?
Minovia Therapeutics treats mitochondrial diseases through cell therapy using its Mitochondrial Augmentation Therapy (MAT) platform. The companys initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments. The company developed a cell therapy approach to treat a broad range of indications generated by a mitochondrial dysfunction. Using its proprietary Mitochondrial Augmentation Technology (MAT), designed to be a robust therapeutic platform combining personalized mitochondrial cell therapy and scalable manufacturing processes, Minovia is advancing breakthrough therapies for patients with mitochondrial dysfunction, caused by disease as well as during aging. Minovia is currently conducting a phase 1/2 clinical trial in patients with Pearson Syndrome.
How much funding has Minovia Therapeutics raised?
Minovia Therapeutics has raised $28.35M in total funding across 5 rounds. The company is currently at the Public stage. Key investors include 4T Ventures, eit health, The Yozma Group.
Who founded Minovia Therapeutics?
Minovia Therapeutics was founded in 2011 by Natalie Yivgi-Ohana (CEO & Co-founder).
What sector is Minovia Therapeutics in?
Minovia Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Healthcare, Patients.
Where is Minovia Therapeutics located?
Minovia Therapeutics is based in HaSadna 3, Tirat Carmel, Israel. The company also has offices abroad.